Budesonide: all 303 studies that test it
Page 2 of 4. Open to participants first (25), then studies with results posted, then the rest; newest registration first within each.
- Study of Budesonide as an Addition to Standard Therapy in Adult Asthmatics in the Emergency Room.CompletedNCT00588406Phase 3Results posted
- A Study of 2 Doses of MAP0010 and Placebo in Asthmatic ChildrenCompletedNCT00569192Phase 3Results posted
- A Study of 2 Doses of MAP0010 in Adult AsthmaticsCompletedNCT00554970Phase 2Results posted
- Symbicort Rapihaler Therapeutic Equivalence StudyCompletedNCT00536731Phase 3Results posted
- Safety and Efficacy Study of Budesonide (Pulmicort®) Turbuhaler® in Japanese Children With Bronchial AsthmaCompletedNCT00509028Phase 3Results posted
- Local Phase 4 Pan-European SMART StudyCompletedNCT00463866Phase 4Results posted
- Budesonide Inhalation Suspension for Acute Asthma in ChildrenCompletedNCT00393367Phase 4Results posted
- Budesonide in Treating Patients With Lung Nodules at High Risk of Developing Lung CancerCompletedNCT00321893Phase 2Results posted
- Budesonide Versus Placebo for the Treatment of Lymphocytic ColitisTerminatedNCT00217022Phase 2/3Results posted
- Effect of Nebulized Budesonide and Oral Corticosteroids on Wheezing Episode Relapse in ChildrenCompletedNCT00189436Phase 4Results posted
- Effect of Symbicort on GR Localisation in AsthmaCompletedNCT00159263Not applicableResults posted
- Childhood Asthma Management Program (CAMP) Phases I (Trial), II (CAMPCS), III (CAMPCS/2), and IV (CAMPCS/3)CompletedNCT00000575Phase 3Results posted
- Budesonide/Formoterol Inhalation Powder in Adults With AsthmaCompletedNCT07790159Phase 3
- Efficacy of Nebulised Inhalational Steroids in Neonates With Meconium Aspiration SyndromeCompletedNCT07763119Phase 3
- Pharmacokinetics and Bioequivalence Study of Budesonide Inhalation Aerosol in HumansCompletedNCT06924190Not applicable
- Comparative Effects of Triple Inhaled Therapy With Budesonide/Glycopyrronium/Formoterol Versus Fluticasone Furoate/Umeclidinium/Vilanterol on Small Airway Disease in COPD Patients: A Randomized Crossover StudyCompletedNCT06905483Phase 4
- Efficacy and Safety of Extended TARPEYO® Treatment Beyond 9 Months in Adult Patients With Primary IgA NephropathyActive, not recruitingNCT06712407Phase 4
- Once Daily Versus Twice Daily Budesonide Orodispersible Tablets for Induction of Remission in EoEActive, not recruitingNCT06596252Phase 3
- Study to Investigate Changes in Airway Inflammation, Symptoms, and Rescue Therapy Utilization With AIRSUPRA Compared to Albuterol as Needed in Adults With Mild AsthmaCompletedNCT06563102Phase 4
- A Study to Evaluate the Effect of Budesonide, Glycopyrronium, Formoterol Fumarate (BGF) Metered Dose Inhaler (MDI), Budesonide and Formoterol Fumarate (BFF) MDI and Placebo MDI on Exercise Parameters in Participants With Chronic Obstructive Pulmonary Disease (COPD).CompletedNCT06067828Phase 3
- Cardiovascular Consequences of Inhaled Short-acting Beta-agonist UseCompletedNCT06027606Phase 1
- The Role of Budesonide Intrapolyp Injection in the Management of Type 2 Chronic RhinosinusitisCompletedNCT05931744Phase 2/3
- Efficacy and Safety of Budesonide MMX® vs. Budesonide CR for Induction of Remission in Microscopic ColitisActive, not recruitingNCT05915104Phase 2
- Efficacy and Safety in Chinese Patients with Immunoglobulin a Nephropathy (IgAN) Who Have Completed Study Nef-301CompletedNCT05534919Phase 3
- Bio-Equivalence Study of Budesonide Prolonged-release Tablets 9 Mg In Healthy Human Adult SubjectsCompletedNCT05519514Phase 1
- The Role of Budesonide Intrapolyp Injection in CRSwNPStatus unknownNCT05474924Phase 4
- In Vivo Performance of Oral Liquid Formulations of Budesonide in the Fasted State in Healthy SubjectsCompletedNCT05429775Phase 1
- Intra-tracheal Instillation of Budesonide to Prevent Chronic Lung DiseaseStatus unknownNCT05364385Phase 4
- Budesonide Multimatrix(MMX) Versus Prednisolone in Management of Mild to Moderate Ulcerative ColitisStatus unknownNCT05341401Phase 2/3
- Comparison of Nebulized Budesonide and Intranasal Budesonide Spray in Children With Adenotonsillar HypertrophyStatus unknownNCT05325489Phase 3
- BE Study Budesonide 80 μg and Formoterol Fumarate Dihydrate 4.5 μg Inhalation Product in Asthma PatientCompletedNCT05322707Phase 3
- Pharmacokinetics, Efficacy, Tolerability and Safety of Different Budesonide Oral Gel Doses in Adults' Subjects of Both Genders With Eosinophilic Esophagitis (EoE)WithdrawnNCT05214599Phase 2
- Single-dose AQ001S PK Study in Healthy VolunteersCompletedNCT05148312Phase 1
- Bioequivalence Study of Budesonide From Ekmasonid 9 mg Extended Release FCT (Hikma Pharma, Egypt) Versus Uceris 9 mg Extended Release Tablets (Man. for: Salix Pharm., a Division of Valeant Pharm. LLC, USA, by: Cosmo S.P.A., Italy by License of Cosmo Tech. Ltd., Ireland, Product of France)CompletedNCT04854538Phase 1
- Three Treatment of Chronic Obstructive Pulmonary Disease PatientsCompletedNCT04520230Phase 4
- A Bioequivalence Pivotal Study of SYN010 HFA Inhaler and Symbicort® 160/4.5 in Healthy Volunteers Without Charcoal BlockCompletedNCT04494321Phase 1
- Efficacy of Budesonide Via Delayed Release vs Immediate ReleaseWithdrawnNCT04476628Early Phase 1
- Coronavirus Smell Therapy for Anosmia RecoveryWithdrawnNCT04422275Phase 2
- STerOids in COVID-19 StudyTerminatedNCT04416399Phase 2
- Trial Evaluating the Efficacy of Local Budesonide Therapy in the Management of Hyposmia in COVID-19 Patients Without Signs of SeverityCompletedNCT04361474Phase 3
- Inhaled Corticosteroid Treatment of COVID19 Patients With PneumoniaCompletedNCT04355637Phase 4
- Epigenetic Health Benefits of BudesonideActive, not recruitingNCT04342039Phase 4
- Assessing Improvement in Cognitive Deficit in CRS in Patients Treated With Medical Vs Surgical ManagementStatus unknownNCT04291118Not applicable
- The Effect of Oral Polymeric Diet Enriched With TGF-beta 2 (Modulen) on Clinical Response and Mucosal Healing in Adult Patients With Newly Diagnosed Crohn's DiseaseStatus unknownNCT04233463Not applicable
- As-needed Budesonide/Formoterol Turbuhaler in Stepping Down PeriodCompletedNCT04215848Phase 3
- The Efficacy of Budesonide/Formoterol in Cough Variant AsthmaStatus unknownNCT04171180Phase 4
- A Study of Intranasal Budesonide Aqueous Spray for Treatment of Rhinitis During Periods of High Airborne PollutionCompletedNCT04132570Phase 4
- Cortiment® MMX Pharmacokinetic StudyCompletedNCT04080713Phase 1
- Compare the Effect of INS Alone and Added LTRA in Treatment of SARCompletedNCT04077892Early Phase 1
- A Comparison of VR647 and Conventionally Nebulized Budesonide in Healthy Volunteers and Adult Asthma SubjectsCompletedNCT04032834Phase 1
- Inhaled Steroids for Acute Pharyngitis.CompletedNCT04027322Phase 2/3
- Nebulized Budesonide Combined With Systemic Corticosteroid in Acute Severe AsthmaStatus unknownNCT04016220Phase 1
- Study of Medication for Nonallergic Rhinitis (NAR) Based on Cluster AnalysisStatus unknownNCT04002349Not applicable
- Oral Viscous Budesonide in Anastomotic Stricture After Esophageal Atresia Repair (OVB in EA)Status unknownNCT03999008Not applicable
- Demonstration of Equivalence and Early Onset of a Novel Anti-allergic Nasal Spray Compared to Marketed Nasal SprayCompletedNCT03755557Phase 3
- Therapeutic Approaches to Malnutrition EnteropathyCompletedNCT03716115Phase 2
- Efficacy and Safety of Budesonide Inhalation Suspension for the Treatment of Chronic Rhinosinusitis With Polyposis.CompletedNCT03687515Phase 3
- Study to Detect Oral Administration of Budesonide in Women.CompletedNCT03537326Phase 1
- Efficacy of Adding Budesonide to Poractant Alfa to Prevent Bronchopulmonary Dysplasia.Status unknownNCT03521063Phase 4
- Impact of Budesonide Irrigations on Patients With Chronic Rhinosinusitis and Impact on Sinus Surgery RatesWithdrawnNCT03519061Phase 2/3
- To Evaluate the Efficacy and Safety of FE 999315 in Japanese Subjects With Mild to Moderate Active Ulcerative ColitisCompletedNCT03412682Phase 3
- Inhaled Steroids for Pediatric Asthma at Pediatric Emergency Medicine DischargeCompletedNCT03369847Phase 4
- Mometasone vs Budesonide in CRS With PolyposisTerminatedNCT03323866Phase 3
- Budesonide for Immunosuppression After Liver Transplantation to Reduce Side EffectsWithdrawnNCT03315052Phase 4
- Comparison of Topical Therapies in Post op Endoscopic Sinus Surgery PatientsWithdrawnNCT03303677Phase 3
- Intratracheal Budesonide/Surfactant Prevents BPDCompletedNCT03275415Phase 4
- Incidence of Acute Laryngeal Injury Following Endotracheal IntubationActive, not recruitingNCT03250975Phase 1/2
- Periostin-guided Withdrawal of Inhaled Corticosteroids in Patients With Non-eosinophilic AsthmaCompletedNCT03141424Phase 4
- Salvational Intervention for Reducing AECOPD Under Severe Air PollutionCompletedNCT03083067Not applicable
- Pharmacokinetic Study to Compare Absorption of Budesonide/Formoterol Easyhaler and Symbicort TurbuhalerCompletedNCT03073057Phase 1
- The RECONSTRUCT Study - Reconstructing Disease Mechanisms in AsthmaCompletedNCT03034005Phase 4
- Clinical Study, Non Inferiority Between Noex® 32µg Versus Budecort Aqua® 32µg in Treatment of Alergic RhinitisWithdrawnNCT02972866Phase 3
- Microbiome Use to Stratify Use of Inhaled Corticosteroids: MUSIC TrialCompletedNCT02972476Phase 4
- Inhaled Budesonide for Altitude Illness PreventionWithdrawnNCT02941510Phase 3
- Treatment Efficacy of Budesonide/Formoterol in Cough Variant Asthma and Typical Asthma PatientsStatus unknownNCT02934945Phase 4
- A Bioequivalence Pivotal Study of SYN010 HFA Inhaler and Symbicort® 160/4.5 in Healthy Volunteers With Charcoal BlockCompletedNCT02850484Phase 1
- A Study to Investigate the Differential Effects of Inhaled Symbicort and Advair on Lung MicrobiotaStatus unknownNCT02833480Phase 2
- Bioequivalence Study of Budesonide Rectal Aerosol Foam and Uceris® Rectal Aerosol FoamCompletedNCT02800824Phase 1
- Low Exhaled NO and ICS in Suspected AsthmaStatus unknownNCT02771717Phase 4
- Efficacy of Once-daily Budesonide/Formoterol Turbuhaler 4.5/160 µg in Step Down AsthmaCompletedNCT02725242Phase 3
- Bioequivalence Study of Two Inhalation Formulations Containing Budesonide 200 µgCompletedNCT02593500Phase 1
- Assessment of Airway Responsiveness and Treatment Efficacy in AsthmaticsStatus unknownNCT02574975Phase 4
- Budesonide 9 mg Capsules in Active UCCompletedNCT02550418Phase 2
- Efficacy of Nebulized Pulmicort Respules in Primary Lung Cancer Patients With COPDStatus unknownNCT02504801Phase 4
- Maintenance of Remission With Budesonide Orodispersible Tablets vs. Placebo in Eosinophilic EsophagitisCompletedNCT02493335Phase 3
- Budesonide Orodispersible Tablet vs. Placebo in Active Eosinophilic EsophagitisCompletedNCT02434029Phase 3
- Nasal Budesonide Efficacy on Nasal FeNO in Children With Allergic RhinitisCompletedNCT02409563Phase 4
- The Effects of Inhaled Glucocorticoids on the Postmenopausal SkeletonWithdrawnNCT02357277Phase 4
- Airway Inflammation in Children With Allergic Rhinitis and InterventionCompletedNCT02352168Not applicable
- Budesonide Effervescent Tablets vs. Viscous Budesonide Suspension vs. Placebo in Eosinophilic EsophagitisCompletedNCT02280616Phase 2
- Pharmacokinetics and Safety Study of PT010 in Healthy SubjectsCompletedNCT02189304Phase 1
- Bioavailability Study of SYN006, Pulmicort pMDI and Meptin Air in Healthy Adult.CompletedNCT02165046Phase 1
- Comparison Between Budesonide and Dexamethasone Treatments for Respiratory Discomfort After Extubation on ChildrenStatus unknownNCT02056379Not applicable
- Effects and Safety of Budesonide Inhalation Suspension Via Transnasal Nebulization in Nasal PolypsCompletedNCT02024659Phase 2/3
- Curosurf/Budesonide for Infants With Respiratory Distress SyndromeCompletedNCT02013115Not applicable
- Therapeutic Effect of Different Treatment Course With Inhaled Corticosteroids in Eosinophilic Bronchitis PatientsCompletedNCT02002715Phase 4
- Asthma Biomarkers for Predicting Response to TherapyStatus unknownNCT01973751Not applicable
- Budesonide vs. Mesalazine vs. Budesonide/Mesalazine Suppository Combination Therapy in Acute Ulcerative ProctitisCompletedNCT01966783Phase 2
- Evaluation of Budesonide and How It Interacts With Antifungal Drugs in People With Gastrointestinal Graft-Versus-Host DiseaseTerminatedNCT01950507Phase 1
- Evaluation of Inhaled Treatment in SinusitisCompletedNCT01907204Phase 2/3